PTI. Pune based drugmaker has partnered with global pharma giant AstraZeneca to produce COVID-19 vaccine by University of Oxford for low-and-middle income countries.
Dubbed as Covishield, the COVID-19 vaccine is currently in the Phase III clinical trial in India. "We have received a confirmation about PM Modi's visit to the Serum Institute of India on Saturday, but his minute-to-minute program is yet to be received," Pune divisional commissioner Saurabh Rao told PTI.The prime minister earlier assured that the government is keeping a close watch on the development of vaccines and is in contact with Indian developers and manufacturers, along with global regulators, governments of other countries, multilateral institutions and international.